Literature DB >> 18489196

Anabolic steroid use: patterns of use and detection of doping.

Michael R Graham1, Bruce Davies, Fergal M Grace, Andrew Kicman, Julien S Baker.   

Abstract

Anabolic-androgenic steroids (AAS) were the first identified doping agents that have ergogenic effects and are being used to increase muscle mass and strength in adult males. Consequently, athletes are still using them to increase physical performance and bodybuilders are using them to improve size and cosmetic appearance. The prevalence of AAS use has risen dramatically over the last two decades and filtered into all aspects of society. Support for AAS users has increased, but not by the medical profession, who will not accept that AAS use dependency is a psychiatric condition. The adverse effects and potential dangers of AAS use have been well documented. AAS are used in sport by individuals who have acquired knowledge of the half-lives of specific drugs and the dosages and cycles required to avoid detection. Conversely, they are used by bodybuilders in extreme dosages with the intention of gaining muscle mass and size, with little or no regard for the consequences. Polypharmacy by self-prescription is prevalent in this sector. Most recently, AAS use has filtered through to 'recreational street drug' users and is the largest growth of drugs in this subdivision. They are taken to counteract the anorexic and cachectic effects of the illegal psychotropic street drugs. Screening procedures for AAS in World Anti-Doping Agency accredited laboratories are comprehensive and sensitive and are based mainly on gas chromatography-mass spectrometry, although liquid chromatography-mass spectrometry is becoming increasingly more valuable. The use of carbon isotope mass spectrometry is also of increasing importance in the detection of natural androgen administration, particularly to detect testosterone administration. There is a degree of contentiousness in the scenario of AAS drug use, both within and outside sport. AAS and associated doping agents are not illegal per se. Possession is not an offence, despite contravening sporting regulations and moral codes. Until AAS are classified in the same capacity as street drugs in the UK, where possession becomes a criminal offence, they will continue to attract those who want to win at any cost. The knowledge acquired by such work can only assist in the education of individuals who use such doping agents, with a view to minimizing health risks and hopefully once again create a level playing field in sport.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18489196     DOI: 10.2165/00007256-200838060-00005

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  104 in total

1.  Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders.

Authors:  H Kuipers; J A Wijnen; F Hartgens; S M Willems
Journal:  Int J Sports Med       Date:  1991-08       Impact factor: 3.118

2.  Anabolic steroid abuse by body builders and male subfertility.

Authors:  F H Lloyd; P Powell; A P Murdoch
Journal:  BMJ       Date:  1996-07-13

3.  Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases.

Authors:  M Garle; R Ocka; E Palonek; I Björkhem
Journal:  J Chromatogr B Biomed Appl       Date:  1996-12-06

4.  Androgenic anabolic steroids and arterial structure and function in male bodybuilders.

Authors:  M A Sader; K A Griffiths; R J McCredie; D J Handelsman; D S Celermajer
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

5.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

6.  Microbial production of testosterone.

Authors:  R F Bilton
Journal:  Lancet       Date:  1995-05-06       Impact factor: 79.321

7.  Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport.

Authors:  M Becchi; R Aguilera; Y Farizon; M M Flament; H Casabianca; P James
Journal:  Rapid Commun Mass Spectrom       Date:  1994-04       Impact factor: 2.419

8.  Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives.

Authors:  M Cicardi; L Bergamaschini; A Tucci; A Agostoni; G Tornaghi; G Coggi; R Colombi; G Viale
Journal:  J Allergy Clin Immunol       Date:  1983-09       Impact factor: 10.793

9.  Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.

Authors:  R Horton; J F Tait
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

10.  Detection of growth hormone abuse in sport.

Authors:  J K Powrie; E E Bassett; T Rosen; J O Jørgensen; R Napoli; L Sacca; J S Christiansen; B A Bengtsson; P H Sönksen
Journal:  Growth Horm IGF Res       Date:  2007-03-06       Impact factor: 2.372

View more
  21 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

2.  Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.

Authors:  Harrison G Pope; Gen Kanayama; James I Hudson
Journal:  Biol Psychiatry       Date:  2011-08-12       Impact factor: 13.382

Review 3.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

4.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

Review 5.  Prevalence of doping use in elite sports: a review of numbers and methods.

Authors:  Olivier de Hon; Harm Kuipers; Maarten van Bottenburg
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

6.  A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men.

Authors:  Melinda Sheffield-Moore; E Lichar Dillon; Shanon L Casperson; Charles R Gilkison; Douglas Paddon-Jones; William J Durham; James J Grady; Randall J Urban
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

7.  Human growth hormone abuse in male weightlifters.

Authors:  Brian P Brennan; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Am J Addict       Date:  2010-11-12

8.  Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

Authors:  Nawed Deshmukh; Andrea Petróczi; James Barker; Andrea D Székely; Iltaf Hussain; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-04-29

9.  Anabolic steroids affect human periodontal health and microbiota.

Authors:  María Isabel Brusca; Fernando Verdugo; Celeste Amighini; Olatz Albaina; María D Moragues
Journal:  Clin Oral Investig       Date:  2013-11-13       Impact factor: 3.573

10.  The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports.

Authors:  Kurt Skårberg; Fred Nyberg; Ingemar Engström
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.